N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.60p
   
  • Change Today:
      0.000p
  • 52 Week High: 0.65
  • 52 Week Low: 0.55
  • Currency: UK Pounds
  • Shares Issued: 832.28m
  • Volume: 128,385
  • Market Cap: £4.99m
2016-10-17 - Suspension of Listing

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -16768.8% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 685.8 n/a
Pr/Book 7.7  
Latest F'cast
Revenue 272.9% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

N4 Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (1.57) (0.96)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (1.84) (0.85)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (1.19) (0.55)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (1.42) (0.52)p n/a n/a n/a n/a 0.0%
31-Dec-24 0.01 (1.22) (0.31)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

N4 Pharma Company Announcements

Interim Results 25-Sep-2025 07:00 RNS
Partnership with University of Strathclyde’... 23-Sep-2025 07:00 RNS
N4 Pharma’s Nuvec® Targets Lung Cance... 22-Sep-2025 07:00 RNS

N4 Pharma ShareCast News

N4 Pharma reports narrower full-year operating l... 06-Jun-2025 ShareCast
N4 Pharma files for new UK patent 04-Dec-2024 ShareCast
N4 Pharma reports positive progress with SRI col... 20-Aug-2024 ShareCast

Latest N4 Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 0.60p
Change Today 0.000p
% Change 0.00 %
52 Week High 0.65
52 Week Low 0.55
Volume 128,385
Shares Issued 832.28m
Market Cap £4.99m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average
Value
55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average55.81% below the market average
70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average70.73% below the sector average
Income Not Available
Growth
25.67% above the market average25.67% above the market average25.67% above the market average25.67% above the market average25.67% above the market average
17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average17.24% above the sector average

N4 Pharma Dividends

No dividends found

Trades for 24-Oct-2025

Time Volume / Share Price
14:17 6,154 @ 0.65p
14:17 154 @ 0.65p
14:17 16,378 @ 0.55p
14:17 1,543 @ 0.65p
09:03 52,078 @ 0.57p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page